Ligand validation:2QJU

DSM: 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE

DSM is a Ligand Of Interest in 2QJU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2QJU_DSM_A_801	45%	5%	0.205	0.938	2.43	2.92	5	17	2	0	100%	1
2QB4_DSM_A_801	78%	28%	0.12	0.963	1.86	1.07	4	1	1	0	100%	1
7Q19_DSM_AAA_201	86%	72%	0.085	0.954	0.34	0.74	-	-	0	0	100%	1
7Q2P_DSM_AAA_502	79%	80%	0.098	0.942	0.15	0.67	-	-	0	0	100%	1
7Q2O_DSM_AAA_202	72%	76%	0.12	0.944	0.25	0.7	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.